First vaccine against four flu strains ready to ship

August 6, 2013
First vaccine against 4 flu strains ready to ship
FDA has approved distribution of new seasonal influenza shot, Fluarix Quadrivalent.

(HealthDay)—The U.S Food and Drug Administration has approved shipping of the first vaccine to protect against four strains of seasonal flu.

The GlaxoSmithKline vaccine, called Fluarix Quadrivalent, was approved by the FDA last December for use in adults and children aged 3 and older. But approved flu vaccines still have to be certified by the FDA each season before they can be shipped to .

Viruses that cause seasonal flu are classified as A or B strains. Most current flu vaccines provide protection against three strains: the two A strains most common in people, and the B strain expected to be predominant in an upcoming .

This is the first season that vaccines protecting against more than three will be available.

"Trivalent [three-strain] influenza vaccines offer important protection against influenza. But since the late 1980s, scientists noted that two B virus lineage strains circulate to varying degrees each year, and it's difficult to predict which one will cause the most illness in a particular . Fluarix Quadrivalent addresses this by protecting against both B strains," Dr. Leonard Friedland, vice president of scientific affairs and public policy at GlaxoSmithKline Vaccines, North America, said in a company news release.

The U.S. Centers for Disease Control and Prevention placed the largest order for Fluarix Quadrivalent—more than 4 million doses—and will distribute those doses to state and local health care providers.

GlaxoSmithKline estimates it will provide up to 10 million doses of quadrivalent in the United States, and 22 million to 24 million doses of influenza vaccine overall. Fluarix Quadrivalent also is approved in Germany and the United Kingdom.

In clinical trials of the new vaccine, the most common negative side effects in adults were pain at the injection site, muscle aches, headaches and fatigue. Negative side effects among children included: pain at the injection site, redness and swelling, drowsiness, irritability, loss of appetite, fatigue, muscle aches, headache and gastrointestinal symptoms.

Explore further: FDA approves first 4-in-1 flu vaccine

More information: The U.S. Centers for Disease Control and Prevention has more about the seasonal flu vaccine.

More Information

Related Stories

FDA approves first 4-in-1 flu vaccine

February 29, 2012
Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

FDA approves flu vaccine for coming season

August 14, 2012
(HealthDay) -- The formulation for the vaccine that will help protect against the flu this coming season was approved by the U.S. Food and Drug Administration on Monday.

Four works better than three: An enhanced flu vaccine does the trick

April 4, 2012
An intranasal vaccine that includes four weakened strains of influenza could do a better job in protecting children from the flu than current vaccines, Saint Louis University research shows.

Mayo Clinic expert explains new vaccine options for next influenza season

July 16, 2013
The next flu shot season will include several new vaccine options for consumers, Mayo Clinic vaccine expert Gregory Poland, M.D., says. Fearful of needles? There's now an influenza vaccination just for you. Allergic to eggs? ...

New research finds flu shot effective regardless of circulating flu strain

June 25, 2013
New research out of St. Michael's Hospital has found that despite popular belief, the flu shot is effective in preventing the flu, even if the virus going around does not match the vaccine.

FDA approves new type of flu vaccine

January 17, 2013
(HealthDay)—The U.S. Food and Drug Administration has approved a novel type of flu vaccine, the agency announced Wednesday.

Recommended for you

Study suggests ending opioid epidemic will take years

July 20, 2017
The question of how to stem the nation's opioid epidemic now has a major detailed response. A new study chaired by University of Virginia School of Law Professor Richard Bonnie provides extensive recommendations for curbing ...

Team-based model reduces prescription opioid use among patients with chronic pain by 40 percent

July 17, 2017
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which ...

Private clinics' peddling of unproven stem cell treatments is unsafe and unethical

July 7, 2017
Stem cell science is an area of medical research that continues to offer great promise. But as this week's paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, ...

Popular heartburn drugs linked to higher death risk

July 4, 2017
Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School ...

Most reproductive-age women using opioids also use another substance

June 30, 2017
The majority of reproductive-age and pregnant women who use opioids for non-medical purposes also use at least one other substance, ranging from nicotine or alcohol to cocaine, according to a University of Pittsburgh Graduate ...

At-risk chronic pain patients taper opioids successfully with psychological tools

June 28, 2017
Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.